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MUSCLE STIFFNESS AS A CAUSE OF REDUCED MUSCLE VOLUME – A RELIABILITY 
STUDY.   
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Director of Thesis: Dr. Zachary Domire, PhD 
 
A leading cause of impairment in elderly individuals is sarcopenia, the progressive 
deterioration of muscle size and strength, which ultimately limits muscle functionality. The loss 
of muscular strength is directly correlated with increased mortality, hypertension, metabolic 
syndrome, and diabetes.  This corresponds with limitations to activities of daily living, therefore 
further restricting the individual’s independence.  The purpose of our study is to test the 
reliability of our methods for measuring muscle volume, stiffness, and strength for future 
sarcopenia research.  We have evidence proving the validity of ultrasound and elastography 
techniques to measure muscle volume and stiffness.  We have targeted the medial and lateral 
gastrocnemius muscles in 6 young adults aged 20-30 years old.  Measurements will be taken 
along the longitudinal axis via ultrasound to determine muscular length.  Muscular area will be 
calculated by taking 5 cross-sectional ultrasound measurements across the muscle.  These 
measurements together will be used to calculate muscular volume, while muscular stiffness will 
be measured using ultrasound elastography.  Isokinetic and Isometric strength tests will be 
performed on the Humac dynamometer and will represent the maximum muscular strength of 
each subject.  A Bland-Altman plot and regression analysis will be performed for each method 
comparing data from the first testing session against the second to verify reliability.  A regression 
analysis will also be performed to determine the relationship between muscle volume, strength 
and stiffness to determine if there is a correlation in a young population. 
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Chapter 1: 
Introduction 
 
 
With age, people may develop sarcopenia, the gradual deterioration of muscle volume 
and muscular strength associated with increasing age.  Although this condition is not present in 
all individuals, it affects about 50% of people over the age of 80 (Baumgartner, 1998).  Muscle 
loss can begin as early as age 30, and muscle volume continues to decline throughout the 
individual’s life span (Waters, 2010).  The loss of muscle size coincides with a decline in 
muscular strength, which ultimately impacts muscle functionality and limits an individual’s 
independence and mobility.  Research has shown that strength in the quadriceps of older adults is 
reduced by 48% compared to younger individuals, which results in a 45-80% increase in the time 
it takes for the individual to walk, climb stairs, and rise from a chair (Haus, 2007).  
Weakness in the lower extremities can reduce an individuals’ independence and impact 
his or her successful participation in activities of daily living.  Reduced muscle functionality can 
affect stability and increase the risk for older adults to fall and acquire injuries that may be 
disabling or fatal (Go, 2013).  Over time, the progression of sarcopenia can continue to increase 
the risk for the individual to develop other serious conditions, such as metabolic syndrome and 
diabetes (Moon, 2013).   These conditions alone increase the individual’s risk for mortality; 
however, research has shown an additional mortality risk factor observed in low handgrip 
strength.  Studies have shown that handgrip strength is a valid representation of an individual’s 
muscular strength (Rantanen, 1999). Overall, there is a negative relationship between handgrip 
strength and all-cause mortality, therefore low muscular strength could increase an individual’s 
risk for premature death (Rantanen, 1999).   
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The health concerns with the progression of sarcopenia have provided significant 
motivation for research to determine a cause of the disease.  Previous studies have already 
established a potential relationship between sarcopenia and changes in nutrition and physical 
activity typically seen in the elderly population.  With old age there is often a diminution in the 
intake of essential nutrients and regular physical activity, which reduces the protein synthesis 
required to maintain muscle volume  (Chapman, 2002); (Park, 2013); (Fry, 2011).  Additional 
research studies have focused on the involuntary effects of aging that could play a role in the 
induction of sarcopenia. This includes the loss of motor neurons and the depletion of anabolic 
hormones with age.  This reduction restricts muscle function and has been expected to play a role 
in muscle hypotrophy (Huh, 2013).   
After reviewing the literature, we consider the previous evidence to be valid in 
determining potential causes for muscle loss and strength decline in old age.  However, we do 
not think this evidence explains the entire cause of sarcopenia. We believe that a reduced 
response to exercise corresponding with old age is a relatively unexplored area that might also 
contribute to sarcopenia. 
Several studies show that elderly subjects experienced a reduced muscular response to the 
designated exercise programs when compared to a younger population (Raue, 1999);(Moritani, 
1980).  Muscular hypertrophy and significant strength gains were observed predominantly in the 
younger populations in both studies (Raue, 1999); (Moritani, 1980). The research shows that the 
elderly subjects experienced some degree of strength improvements, but limited muscular 
hypertrophy in response to the exercise programs (Raue, 1999);(Moritani, 1980).  The increase in 
muscular strength may result from increased neural stimulation following the training especially 
when considering the lack of muscular hypertrophy (Moritani, 1980).  
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Studies have linked the strength and hypertrophic restrictions to differences in gene 
expression and cell signaling between young and old populations.  IGF1 and CNTF are both 
significant muscle mass regulators that have shown to be drastically reduced as a result of aging 
(Dennis, 2007).  On the other hand, higher levels of the negative regulator GDF8 were found in 
older adults compared to younger adults following an exercise program (Dennis, 2007).  
Research also shows an increase in REDD1 mRNA in older women due to the bodies’ failure to 
downregulate the gene after resistance training (Grieg, et al, 2011).   Downregulation of REDD1 
mRNA is essential to ensure the upregulation of mTOR signaling which signals protein synthesis 
(Grieg, et al, 2011). Researchers have concluded that the disruption of protein synthesis due to 
certain gene alterations can affect an elderly individual’s hypertrophic response following an 
exercise program (Dennis, 2007);(Grieg, et al, 2011).  
Statement of the Problem 
The limited hypertrophic response and altered gene expression in older adults may result 
from changes in the mechanotransduction process due to increased muscular stiffness.  Stiffening 
of the muscle cell can result from an accumulation of advanced glycation end products (AGE’s) 
that are found in elderly skeletal muscle (Haus, et al, 2007).  This buildup disrupts the 
breakdown of proteins, leading to an increase in collagen crosslinks and deformed collagen 
fibers - which further contributes to muscle stiffness.  Muscle stiffness causes the cell membrane 
to become inflexible and limits stretching in response to an external stimulus.  We believe this 
interferes with the mechanotransduction process, as the strain receptors are unable to detect the 
force and stimulate protein synthesis.  Over time, the muscle will undergo hypotrophy due to a 
lack of regular forces acting upon it. 
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Hypothesis  
Our hypothesis is that muscular atrophy and attenuated muscular strength is related to 
increased muscle stiffness. 
Significance of the Study 
The elderly population is expected to rise significantly in the next decade and with this 
will come an increase in sarcopenia cases. Due to the health risks associated with muscular 
atrophy, there are significant benefits to understanding the derivation of the disease. Our long 
term research goal is to evaluate muscle stiffness as a possible explanation for the development 
of sarcopenia.  With an understanding of another potential cause of sarcopenia, future efforts can 
be made towards designing an intervention that may reduce the prevalence of sarcopenia in older 
individuals.  
Our current study will provide the foundation for future sarcopenia research.  We targeted 
a younger population to test the accuracy and practicality of our methods of measuring muscle 
volume, stiffness, and strength.  If our methods are reliable, we can test for evidence of any 
correlation between the three factors in a younger population for future comparison.  After we 
ensure the reliability of the testing procedures we will expand the research by including elderly 
subjects to research the affect of age-related muscle stiffness on muscle physiology. 
Delimitations 
This study is limited to a population between the age of 20-30 in order to refine the 
testing procedures before involving older subjects. To avoid differences in sex hormones and the 
possible affect on muscle composition and the muscular response to exercise, we have limited 
the study to females only. 
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Limitations 
Our subjects are all aged between 20-30 years old and have yet to experience signs of 
sarcopenia.  We have restricted ourselves by not collecting data from an older population.  By 
studying the relationship between muscle size and muscle stiffness, we have limited ourselves to 
be able to determine only a correlation, not causation between the three factors.  In addition, we 
are not directly studying the reduced response to exercise following a particular resistance-
training program, therefore there could be several other factors contributing to sarcopenia. 
Definitions 
i. Sarcopenia - the gradual deterioration of muscle volume and muscular strength  
ii. IGF1 – a growth factor that controls muscle volume due to a mechanical or 
hormonal stimulus (Dennis, 2007). 
iii. CNTF – a cytokine that regulates protein synthesis and promotes muscle 
excitation by preventing the death of motor neurons (Dennis, 2007). 
iv. GDF8 – a negative regulator of muscle hypertrophy – lower levels result in 
higher muscle mass.  GDF8 decreases following an exercise program, however 
the duration in which this depletion occurs is individual specific (Dennis, 2007).  
v. Mechanotransduction – the transformation of physical forces into chemical 
signals that stimulate muscle movements (Shwartz, et al, 2013).  Stretch receptors 
on the cell membrane sense an external stimulus and release chemicals that signal 
protein synthesis (Wu, et al, 2011) 
vi. AGE’s – Advanced glycation end products – glycated proteins that result from 
the prolonged contace of monosaccarides with protein residue (Haus, et al, 2007) 
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Chapter II: 
Review of Literature 
 
 
 This literature review will include background information on the prevalence and 
negative effects of sarcopenia on health and independence.  Furthermore, it will include potential 
causes of muscular atrophy studied in previous research followed by evidence supporting our 
hypothesis involving muscle stiffness.  In addition, the review will cover the prospective causes 
of muscle stiffness with age, along with a summary, which briefly covers implications for further 
research. 
Sarcopenia 
A leading cause of impairment in elderly individuals is sarcopenia, the progressive 
deterioration of muscle size and strength, which ultimately limits muscle functionality.  The 
onset of muscle atrophy can occur around age 30, as individuals tend to lose about .5 pounds of 
muscle a year, combined with a gain of 1 pound of fat (Waters, 2010). By age 60, about 40% of 
the muscle cross sectional area is lost (Waters, 2010).  The rate of muscle loss is not consistent 
with all individuals; a variety of factors also play a role, such as nutrition, physical activity level, 
and ethnic and environmental factors (Huh, et al, 2013). Sarcopenia exists in about 15% of 
individuals greater than 65 years of age and increases to about 50% around 80 years of age 
(Baumgartner, 1998). 
In sarcopenia, Type II muscle fibers are cannibalized, accounting for the majority of the 
total loss in muscular strength (Lexell & Taylor, 1991). This is due to the fact that Type II 
muscle fibers are fast twitch fibers and promote 5-6 times the power exerted by the Type I 
muscle fibers (Haus, Carrithers, Trappe, & Trappe, 2007).  Research shows that with age, 
maximum power of the quadriceps muscle decreases by 48% (Haus, 2007).   
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Effect on Quality of Life 
The loss of muscular power and function in an elderly individual can affect activities of 
daily living and reduce independence.  It was determined that the time it takes for individuals to 
climb stairs, rise from a chair, and walk is increased by 45-80% with old age (Haus, 2007).  The 
mobility restriction and limited ability for a person to rise from a chair or a bed may require 
modified accommodations to satisfy the individual’s changing needs (Rosenberg, 1997).  
Reduced mobility oftentimes forces the patient to use a cane or a walker to promote better 
balance during walking (Go, et al, 2013).  Balance issues associated with sarcopenia make 
affected individuals prone to injuries due to the high prevalence of falling (Go, et al, 2013).  
There is a positive relationship between the amount of injuries to the hip and femur relative to 
the amount of falls in older adults (Jorgenson, 2014).  There is a positive association between 
mortality and falls as well for older individuals especially due to injuries resulting in 
hospitalization and decreased functionality (Jorgenson, 2014).  A common injury resulting from 
falls is a hip fracture, which affects both the individuals’ mental and physical state.  Following a 
hip fracture, most individuals don’t return to their previous physical state and therefore become 
more dependant on others due to their prolonged disability (Karni, 2014).    
The consequences of sarcopenia are not only physical, but mental as well.  Sarcopenia 
can affect an individual’s emotional state by causing anxiety and depression both of which are 
fairly common amongst the patients (Go, et al 2013).  Falls and the resulting injuries reduce the 
individual’s self-efficacy in their ability to move and participate in regular activities of daily 
living (Karni, 2014).  The associated consequences of sarcopenia can result in negative attitudes 
toward physical activity, sociality, and the individual’s quality of life (Karni, 2014).  
 
 8 
Effect on Health and Mortality 
Over time, the mental and physical consequences to sarcopenia described above can lead 
to other serious health concerns. Studies have shown that sarcopenic individuals are at an 
increased risk for hypertension, obesity, and elevated triglyceride and glucose levels –all of 
which are symptoms of metabolic syndrome (Moon, 2013). The risk for insulin sensitivity and, 
as a result, diabetes is significantly increased in sarcopenic individuals as well (Moon, 2013).  
The prevalence of these diseases amongst the sarcopenic population occurs mostly in adults 
greater than 60 years of age – there is no correlation between muscle strength and these 
metabolic diseases in the younger population between 20-39 years of age (Moon, 2013).  These 
diseases occurred independently from BMI, meaning low muscle volume has a greater influence 
on health and mortality than body weight alone (Rantanen, 2000). However, the risk for disease 
was further increased in the sarcopenic population if an individual was obese (Moon, 2013).   
These health concerns can ultimately predict increased mortality due to muscular strength 
loss.  Overall, those with lower handgrip strength experienced two times the greater risk for 
mortality and disablement in old age (Rantanen, 1999).  The risk of death may result from 
damages obtained through the development of the sarcopenia related diseases above.  Studies 
show that low muscular strength impairs the body’s ability to repair tissue, which leads to lower 
survival rates from chronic diseases and hospitalizations (Rantanen, 2000).  Reduced tissue 
repair can result from and promote further injuries, which along with reduced muscular strength, 
can limit an individual’s functionality (Rantanen, 2000). 
Adverse health conditions are not only a result of sarcopenia, but may also contribute to 
the problem.  Diseases and abnormal health problems may promote discomfort and unsteadiness 
in an individual, which lowers physical activity levels.  This process ultimately comes full circle 
 9 
as lower physical activity levels lead to an increased risk for future health problems and the 
development of sarcopenia.  
Health Care Costs 
The development of detrimental health conditions and the associated disabilities can put 
health and financial stress on the affected person. The loss of strength associated with sarcopenia 
results in lower health quality and an increased risk for injury.  In 2000, the estimated health care 
costs from injuries associated with sarcopenia was about $18.5 billion and is expected to rise in 
the near future as the elderly population increases (Janssen, 2003).  This value covered costs 
from hospital visits, outpatient care, and home health.  The estimate didn’t take into account the 
monetary sacrifice due to a lack of the patient’s productivity (Janssen, 2003). 
Causes of Sarcopenia 
 The increased prevalence of disabilities, health concerns, and the resulting health care 
costs due to sarcopenia have sparked interests in investigating the potential sources of the 
problem. Previous studies have researched connections between several aging factors and the 
onset of sarcopenia.  The results have shown that neural loss, a reduction in anabolic hormones, 
changes in nutrition and physical activity, and a reduced response to exercise all trigger 
sarcopenia and result in muscular atrophy.   
Neural Loss 
Previous studies have predicted that sarcopenia may result from neural loss that correlates 
with increasing age.  With decreased mobilization due to aging, some motor units become 
dysfunctional and deinnervate from the muscle cell, resulting in cell death (Kaya, et, al, 2013).  
Cell death mainly occurs in motor units connected to Type II fibers and contributes to muscular 
deterioration with age.  With an overabundance of Type 1, slow twitch muscle fibers, the firing 
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rates of the remaining motor units decrease resulting in slower, less stable movements (Erim, 
1999).  The unattached nerve fibers can reinnervate to surrounding muscle fibers, however, this 
can result in the loss of fine-tune movement, due to the excessive accumulation of Type I fibers 
on a single muscle fiber (Erim, 1999).  The deinnervation and reinnervation process that occurs 
with age affects the signal from the brain to the muscle fiber and the muscle loses overall power 
(Kaya, et al, 2013).   
Changes in Anabolic Hormones  
With age comes an insufficiency in anabolic hormones as well.  Testosterone is a major 
determinant for the growth and maintenance of skeletal muscle and bone (Huh, 2013).  With age, 
testosterone levels decrease in both men and women and eventually lower the muscle mass 
volume.  Women have a significantly lower amount of testosterone than men, therefore the 
depletion of testosterone impacts male muscles to a greater degree (Huh, 2013).  The more 
prominent reduction of testosterone in men can explain the early onset of sarcopenia in men 
compared to women (Huh, 2013). Estrogen has a smaller influence on the muscle, however, it is 
an important contributor to muscle functionality and it limits fat penetration in the muscle (Park, 
2013).  
Changes in Nutrition 
Changes in nutrition are customary in the elderly population and these modifications are 
suspected to play a key role in the development of sarcopenia (Chapman, 2002).  Aging results in 
dietary alterations due to premature satiety and adaptations to taste, changing social conditions, 
and monetary status that correspond with old age (Chapman, 2002); (Buford, 2010).  The 
popular phrase “anorexia of aging” refers to the diminution of food and energy intake that occurs 
with age progression (Chapman, 2002).  A decrease in food intake drastically lowers the 
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nutrients and energy available for protein synthesis and can result in a decrease in muscular 
volume.  Protein synthesis doesn’t occur as rapidly or efficiently in elderly individuals, therefore 
an increase in protein ingestion is expected to maintain muscle volume (Chapman, 2002).  
Studies show that those with sarcopenia consumed a lower amount of protein, carbohydrates, and 
energy than their estimated energy requirement (EER) compared to those with a healthy muscle 
mass (Park, 2013).  Overall, 40% of elderly individuals don’t consume the required amount of 
protein, therefore the risk for sarcopenia enhances with old age (Burton, 2010).      
Elderly individuals are more susceptible to an insufficiency of Vitamin D as well due to a 
lack of sunlight exposure and a decrease in the efficiency of Vitamin D synthesis (Park, 2013).  
Vitamin D has been linked to muscle fiber maintenance and increased muscle functionality, 
especially in the lower extremities (Park, 2013).  Muscle function is feasible through the 
production and availability of ATP as well, which is controlled by creatine.  With age, there is a 
lack of obtainable creatine available for the body to produce adequate levels of ATP. Shortages 
of ATP during exercise and activities of daily living promote muscle failure, fatigue, and 
strength loss (Rom, 2012).  
Changes in Physical Activity 
According to the CDC, the physical activity guidelines for older adults include 150 
minutes of moderate intensity aerobic exercise or 75 minutes of vigorous aerobic activity a week 
combined with at least 2 days of muscular strengthening activities (Center for Disease Control, 
2011).  Overall, a large amount of the elderly population doesn’t acquire the recommended 
amount of physical activity (Fry, 2011).  Protein synthesis depends on a mechanical stimulus and 
without the recommended amount of physical activity, the body is unable to maintain protein 
production (Fry, 2011).  
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Aerobic activity increases the transport and usage of nutrients in the muscle 
(Timmerman, 2012). A deficiency of regular aerobic exercise can lead to hypotrophy, increased 
fat infiltration of the muscle, and a decrease in functionality due to a lack of protein synthesis.   
A reduction in resistance exercise can cause a greater decline in muscular strength and results in 
slower gait speeds, loss of balance, and reduced physical function (Burton, 2010).  Regular 
resistance exercise can improve joint mobility and muscle function, while decreasing pain that 
might limit individuals from being physically active (Shwartz, et al, 2013).  Therefore, by being 
physically active, an individual can possibly reverse the effects of sarcopenia and increase 
muscular volume. 
Reduced Response to Exercise  
Regular physical activity may not prevent the onset of sarcopenia in all older adults, 
however. The progressive loss of muscle mass in older individuals can potentially be explained 
by a reduced muscular response to exercise.  In 2009, Raue produced a study proving that 
following a resistance-training program, elderly individuals experienced a lower muscular 
hypertrophic response to exercise compared to the younger subjects.  Similar results were 
discovered in a study by Moritani and deVries in which a significant increase in muscular cross 
sectional area was apparent in the younger population following an exercise program, but not in 
the elderly participants (Moritani, 1980).  When evaluating muscular strength, both age groups 
improved in response to the resistance training, however strength gains were more apparent in 
the younger population as well (Raue, 1999);(Moritani, 1980).  The observed strength 
improvement in the older population was deemed to be more dependant on increased neural 
stimulation, without a strong influence from muscle hypertrophy (Moritani, 1980).   
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The limited response to exercise is also demonstrated through limited gene expression 
with age.  IGF1 is the most prevalent growth factor that responds to mechanical stimuli in order 
to promote and maintain muscular growth (Dennis, et al., 2007).  Research comparing muscle 
composition between the young and old populations has shown that this growth factor is 
significantly diminished in the older population (Dennis, et al., 2007).  Other factors, such as the 
CNTF growth factor, are also drastically reduced in the elderly population (Dennis, et al., 2007).  
This factor is responsible for neuron survival; therefore a decrease in this gene concentration will 
reduce muscle excitation, cell differentiation, and protein synthesis, all of which can ultimately 
limit muscular hypertrophy (Dennis, et al., 2007).   
Protein synthesis can be halted by an overabundance of negative regulatory factors as 
well.  The diminution of REDD1 mRNA following resistance exercise in the young population 
results in increased mTOR signaling and consequently the augmentation of protein synthesis 
(Grieg, et al, 2011).  In the elderly population, REDD1 mRNA is not downregulated following 
the exercise program, leading to limited mTOR signaling for protein synthesis (Grieg, et al, 
2011). A superfluity of the negative regulator GDF8 is also more prevalent in the elderly 
population following an exercise program, when compared to the younger population (Dennis, 
2007).  In this case, a lesser amount of the regulator results in increased muscle mass (Dennis, 
2007). The reduction and overabundance of certain growth factors in the elderly population can 
possibly play a role in the induction of sarcopenia, even if the patient participates in regular 
exercise.  Over time, the muscle will undergo atrophy due to the lack of a cellular response to the 
external forces acting upon it.  As the strain sensitive receptors undergo less stimulation, the 
muscle cell will eventually decrease in size to compensate for the long-term decrease in 
perceived mechanical signaling.   
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We have chosen to focus our research on the reduced response to exercise as a possible 
cause of sarcopenia. However, if it is not a factor in muscular atrophy, the limited hypertrophic 
response in elderly adults still affects the treatment of sarcopenia and should undergo further 
research.     
Mechanotransduction 
To explain the reduced hypertrophic response to exercise, our overall research project 
focuses on alterations to the mechanotransduction process in order to target the first step in the 
mechanical signal transmission leading to protein synthesis.  We believe that focusing on the 
first step of the transmission process will help us to determine the root of the signaling problem. 
Mechanotransduction is the transformation of physical forces into chemical signals that stimulate 
muscle development (Shwartz, et al, 2013).  During this process, stretch receptors on the cell 
membrane sense an external stimulus, analyze the signal, and respond by releasing chemicals 
(Wu, et all, 2011).  In younger individuals, the connective tissue surrounding the muscle cell 
stretches in response to an external force.  As muscle cells age, they become inflexible and 
stretch less in response to the mechanical stimulus.  With less muscular strain, the cell is 
unresponsive and doesn’t release the chemicals necessary to activate certain pathways or 
enzymes responsible for protein production (Fry, 2011).  
Chemicals released by the stretch receptors trigger signaling pathways used to 
phosphorylate and stimulate certain proteins necessary for a muscular hypertrophic response.  
These pathways are load dependant, meaning that protein synthesis occurs only when an external 
force acts on the muscle (Klossner, 2009). An example of a signaling pathway is the 
FAK/p7056k pathway in which focal adhesion kinase (FAK) reacts to the external force and 
activates the p7056k protein to increase muscle hypertrophy (Klossner, 2009).  With age, there is 
 15 
a decrease in the FAK phosphorylation, therefore limiting pathway signaling from the muscle 
stretch receptors and reducing protein synthesis  (Rice, 2007).  In older individuals, the 
mTORC1 and MAPK signaling pathways are also inhibited, therefore resulting in reduced 
protein synthesis (Fry, 2011).  This diminution results in a loss of muscular strength and mass 
due to a weakened cellular response to exercise.  In other words, the muscle is not able to gain 
the benefits associated with resistance exercise (Fry, 2011).   
Causes of Muscle Stiffness 
There are several explanations for the decreased stretch and inflexibility of the muscle 
cell membrane with advancing age.  Muscle fiber connective tissue in older muscle contains an 
increased amount of advanced glycation end products (AGEs) resulting from the prolonged 
contact of monosaccarides with protein residues (Haus, et al, 2007).  AGEs are common in 
diabetics of all ages, but are also prevalent in the non-diabetic elderly population (Haus, et al. 
2007).  AGEs build up in immobile, elderly individuals because there is a lack of the mechanical 
stimulus required for normal tissue turnover (Haus, 2007).   
AGEs diminish the efficiency and breakdown of proteins; therefore leading to an 
accumulation of inefficient proteins (Snow, et al, 2007).  Studies show that aging increases AGE 
count by 200%, which in addition to a decrease in protein competency, results in a loss of 
collagen cross-linking, deformed collagen fibers, and impeded cellular communication (Haus, et 
al, 2007); (Reddy, 2004).  Each muscle fiber is surrounded by a connective tissue supported by 
an arrangement of collagen fibers that provide structure and strength to the fiber (Haus, et al., 
2007).  Studies found that with age, the number and arrangement of collagen fibers remained the 
same, however, the linkage between fibers increased (Gao, 2007).  Some studies have shown that 
with increasing age, collagen production increases as well.  For this to be possible, an increase in 
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collagen breakdown must coincide with the increase in production in order for collagen content 
to appear unrelated to age (Haus, et al., 2007).   The increase in AGEs, collagen cross-linking, 
and a possible increase in collagen production stiffens the connective tissue surrounding the 
muscle fiber, therefore reducing cellular flexibility in response to an external stimuli. 
Summary 
 Muscular atrophy and strength loss with age affects activities of daily living and 
individual functionality.  By the year 2030, the United States population above age 65 is 
expected to reach 72 million, compared to the 41.4 million currently reported (Kaya, et al, 2013).  
Of these individuals, 15%-50% of them will develop sarcopenia and will have an increased risk 
for injury and mortality (Baumgartner, 1998).  With sarcopenia comes strength loss, balance and 
mobility problems, and decreased independence (Go, et al, 2013).  Furthermore, there is a 
positive relationship between declining muscular strength and mortality (Jorgenson, 2014).  
Those with sarcopenia have an increased risk for developing injuries, diabetes, metabolic 
syndrome, and insulin resistance, all of which could result in an early death (Moon, 2013).   
 Previous researchers have discovered a connection between sarcopenia and neural loss 
(Kaya, et, al, 2013)(Erim, 1999), changes in physical activity and nutrition, and a loss in anabolic 
hormones.  After reviewing these theories, we have focused our research on a new hypothesis 
based on the reduced muscular response to exercise that is seen in the elderly population.  The 
overall theory is that older individuals have a decreased muscular response to activity due to 
impairment in the mechanotransduction process.  This muted cellular response ultimately will 
result in the loss of muscle mass.  The muscle cell stiffens with age and therefore, stretch in 
response to a mechanical stimulus is reduced.  The strain sensitive receptors will then undergo 
less stimulation, and the muscle cell will eventually decrease in size.  The specific research I will 
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conduct will evaluate the methods used for further research on the relationship between muscle 
size, stiffness, and strength.  Our overall hypothesis is that with age, the muscle may stiffen and 
result in reduced muscular volume. 
 Muscle stiffness with aging can result from several factors including an increase in the 
development of AGE’s and the multiplication of collagen cross-links.  Knowing this information, 
possible interventions can be established and applied to aging individuals to reduce muscle 
stiffness.  By decreasing muscular stiffness, there is the possibility that the overall prevalence of 
sarcopenia could diminish in older individuals.     
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Chapter III: 
Methods 
 
 
Purpose 
The purpose of the study was to test the reliability of our methods for measuring muscle 
volume, stiffness, and strength for future sarcopenia research.  
Subjects 
Six healthy female subjects were tested between the ages of 20-30 years old.  The subjects 
were all in good health, nonsmoking, and had a BMI less than 27 kg/m2.  The Institutional 
Review Board approved all protocol before the subjects were tested. 
Data Collection 
Each subject participated in two separate testing sessions.  During each session, the subject 
underwent ultrasound, elastography, and strength testing.  Ultrasound imaging was used to 
determine muscular volume (Infantolino, et al, 2007). Data was collected via the Aixplorer 
ultrasound system (Supersonic Imagine, Aix-en-Provence, France) using 2D technology.  The 
imaging depth was set to 6 cm to account for all muscle sizes and to ensure that the entire depth 
of the muscle was visible in the image. 
The study focused on the volume of the medial and lateral gastrocnemius muscles of the 
right calf.  The gastrocnemius muscles were traced from the distal insertion points at the Achilles 
tendon to the proximal insertion points at the medial and lateral condyles.  Longitudinal 
ultrasound scans were taken along this axis from the distal insertion point of each muscle 
towards the proximal insertion point to determine muscular length in centimeters.     
To measure muscular cross sectional area at specific locations across the muscle, the 
longitudinal axes of the medial and lateral gastrocnemius muscles were divided and marked into 
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five equal segments.  The longitudinal axis began one centimeter in from each end of the muscle.  
At every muscle slice, a cross-sectional ultrasound image was taken beginning at the lateral 
border of each muscle and moving towards the medial border. Each ultrasound scan was 
performed two times and an average was taken to provide the final measurement value.  Separate 
ultrasound measurements were taken from both muscles. 
To measure muscle stiffness, we used elastography - a new technology that projects sound 
waves into the muscle causing the tissue to vibrate.  The machine measures the travel rate of the 
shear vibration waves to determine muscle stiffness (Eby, et. al, 2013).  The machine assesses 
the muscle stiffness of the gastrocnemius muscles as stiff tissue transmits the waves faster than 
less stiff tissue.  Stiff tissue was recorded as a yellow-red color and less stiff muscle appeared as 
a blue color. 
Before testing, the machine was set for 100 kPa. The probe was placed on the center of 
each muscle belly and held for 10 seconds while the device recorded the shear waves transmitted 
through the muscle.  The probe was placed at this location because this is generally the thickest 
part of the muscle and best represents the stiffness of the muscle as a whole.  Three elastography 
readings were taken from the same location on each muscle for both testing days.   
To determine muscular strength we performed both isometric and isokinetic strength tests 
on the Humac dynamometer.  The isometric test was designed to test the ankle planter flexor 
strength at 0 degrees of flexion for a series of 5 trials.  These trials were performed at the 
subjects’ maximum strength level and held for 10 seconds after which a resting period began 
before the next trial.  The isokinetic test targeted only concentric plantar flexion at 60 degrees 
per second of ankle flexion.  The test consisted of 5 trials as well, in which the subjects 
performed at maximum capacity.  
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Processing the Data 
The ultrasound images were uploaded into the OsiriX software program to electronically 
calculate the muscular length and cross-sectional area.  The closed polygon feature of the 
program allowed the user to outline the muscle in each ultrasound image and the numerical area 
values were automatically presented.  To determine the length, the user would select the length 
feature and draw a linear line from the distal to the proximal muscle boundaries and the length 
value was automatically presented. 
To determine muscle volume, we took the total length of the muscles (minus 2 cm) and 
divided this value by 5 to determine the longitudinal length between each muscle slice.  The 
separate length values were multiplied by the average of the cross sectional areas of the two 
bordering slices.  The average was calculated to compensate for the size discrepancy of the two 
adjacent muscle slices.  To calculate the volume of the end segments of the muscle, we estimated 
them as cones and multiplied the cross-sectional area of each end slice by 1/3 and by the length 
of the end muscle slice.  After performing these calculations, we added all values together to 
determine the ultimate muscle volume.  
The stiffness of each trial was determined by using the Q-Box function at the middle of 
each ten-second clip.  This function placed a 2 mm circle in the center of the clip frame to 
designate the area where the muscle stiffness was measured.  Upon the placement of the circle, 
the modulus mean value and the standard deviation values were automatically shown.  An 
average was taken of the three modulus mean values recorded from the trials to represent the 
overall muscle stiffness.  
Muscular strength data was exported from the dynamometer into separate excel 
spreadsheets.  The strength values from the 5 trials were presented in a graph showing the peak 
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force values.  The largest peak represented on the graph determined the subject’s maximum 
force.  Isometric and isokinetic strength data were displayed on two separate graphs; therefore 
muscular strength was denoted by two values. 
Statistics 
 To check the accuracy of our methods for obtaining volume, stiffness, and strength data 
we plotted the values from day 1 against day 2.  Using this plot, we located the line of best fit 
and established the coefficient of determination, which was used to verify a correlation.  We also 
conducted Bland-Altman assessments to demonstrate the level of intra-reliability in our methods.  
The range of agreement was set at +/- 2 SD.  This graph plotted the difference in data values 
between the two testing sessions against the overall mean of the day 1 and day 2 values.  
Through this analysis, we were able to determine the percent error in our methods and the 
standard deviation of the data points.      
 The repeat bias in muscle size, stiffness and strength was determined by performing an 
independent-sample t-test.  The significance of the data variance was represented by a 
corresponding p-value.  The data was considered significant if the p-value was less than or equal 
to 0.05. 
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 Chapter IV:  
 Results 
 
Muscle Volume. The data in Table 1 displays the calculated muscle volumes of the 
medial gastrocnemius (MG) and lateral gastrocnemius (LG) muscles over the two-day testing 
period.     
Table 1: Muscle Volume Measurements (in cm3) 
Subject Medial Gastrocnemius Lateral Gastrocnemius 
 Day 1 Day 2 Day 1 Day 2 
1 201.893 229.086 124.718 126.121 
2 190.164 223.041 142.109 123.455 
3 169.204 172.34 93.228 122.197 
4 106.829 118.525 59.033 64.864 
5 147.898 142.637 98.53 115.699 
6 206.549 216.22 119.673 113.513 
 
Although there are particular discrepancies in data from day 1 compared to day 2, Figure 
1 shows a positive correlation in the testing reliability of the measurements taken between the 
sessions.  The correlation of determination is .91, which proves that the differences in volume 
may be insignificant when determining relative muscle volume.     
Figure 1: Volume Testing Reliability 
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Figure 2 shows the Bland-Altman assessment of agreement between the two testing days.  
The range of agreement was set at +/- 2 SD.  This is reflected in the mean bias of 5.838, which 
determines that these variances are likely due to systematic error.  Data from the MG shows a p-
value of .07, which although it is not significant, it shows there is a trend suggesting possible 
bias in our methods.  This bias is not evident in the LG, as shown by a p-value of .52.  The 
percent error for the data set is 15%, which signifies that our methods were satisfactory for 
obtaining muscle volume.   
Figure 2:Bland-Altman Analysis of Muscle Volumes Between Testing Sessions 
 
Muscle Stiffness.  The muscle stiffness values in Table 2 are averages of three consecutive 
elastography readings taken during each testing session.  Most subjects displayed a wide range of 
stiffness values amongst the consecutive measurements; meaning outlying data could have 
influenced the mean.  The data shows discrepancies between day 1 and day 2 for several of the 
subjects, as seen with muscle volume. The stiffness values for subjects two and six varied 
between day 1 and 2 in the MG, while subjects one and four displayed significant stiffness 
variations in the LG between test days.   
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Table 2: Muscle Stiffness Measurements (in kPa) 
Subject Medial Gastrocnemius Lateral Gastrocnemius 
 Day 1 Day 2 Day 1 Day 2 
1 17.5 16.6 20.7 34.03 
2 16.4 27.8 18.4 20.9 
3 19.8 23.6 17.6 21.4 
4 26.3 24.6 20.7 34.4 
5 13.2 13.7 19.2 10.7 
6 21.2 13.5 22.8 18.1 
 
The Bland-Altman analysis in Figure 3 displays a relatively equal number of subjects 
with negative error opposed to positive.  This is reflected by a mean bias of 2.128, which is fairly 
close to 0.  This proves that there was considerable random error in testing, opposed to a 
systematic error between testing sessions.  Data from both the LG and MG show p-values of .41 
and .74, respectively, which demonstrates a lack of evidence for bias in our testing methods.   
Figure 3: Bland-Altman Analysis of Muscle Stiffness Between Testing Sessions 
 
The percent error of the analysis in Figure 3 is 73.88%, therefore proving inconsistency 
in the methods.  Figure 4 demonstrates the testing reliability when the stiffness data from day 1 
was plotted against that of day 2.  Based on the Figure, there is a weak correlation between 
testing sessions, with a coefficient of determination being 0.06343. 
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Figure 4: Elastography Testing Reliability 
 
Muscular Strength. The results from the isometric and isokinetic strength tests displayed 
in Table 3 represent the peak forces exerted by the subjects in a series of five trials.  The peak 
isokinetic torque was relatively uniform between test days for subjects 4, 5, and 6.  However, 
data from the remaining subjects portray strength discrepancies between days 1 and 2.  This was 
evident when studying the additional trials as well. 
Table 3: Calf Strength Measurements (in Nm) 
Subject Isometric Isokinetic 
 Day 2 Day 3 Day 2 Day 3 
1 30.92 48.54 66.72 29.43 
2 135.74 141.02 79.19 90.45 
3 101.02 109.97 72.14 105.9 
4 74.17 75.39 53.7 54.51 
5 97.77 95.46 76.21 79.46 
6 70.51 86.51 41.76 48.27 
 
Isometric Muscular Strength.  Figure 5 displays the Bland-Altman analysis of the data 
comparing the two testing sessions.  Five out of six subjects’ strength improved during the 
second testing session.  This is reflected by a mean bias of 7.793, which likely means these 
discrepancies were due to systematic error.    Isometric strength data shows a p-value of .06, 
which is not significant, however it demonstrates that there is a trend that may provide evidence 
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of a bias in our methods. The percent error was 17.91% between testing sessions.  This is evident 
in Figure 6, which displays the testing reliability when plotting isometric strength data from day 
1 against day 2.  The Figure shows a strong positive correlation with a correlation coefficient of 
0.9574. 
Figure 5: Bland-Altman Analysis of Isometric Strength Between Testing Sessions 
 
Figure 6: Isometric Strength Testing Reliability 
 
  
Isokinetic Muscular Strength.   Figure 7 displays the Bland-Altman analysis of agreement 
for the isokinetic strength values between testing sessions.  It is apparent that some subjects 
performed better on the 2nd testing day compared to the first.  This is reflected in a mean bias of 
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3.05, however a p-value of .76 suggests there is not evidence of significant bias in our data.  The 
percent error for this data was relatively high at 72.7%.    
Figure 7: Bland-Altman Analysis of Isokinetic Strength Between Testing Sessions 
 
Figure 8 displays a fairly weak positive correlation between isokinetic strength values 
between testing days.  The coefficient of determination is .3678 for this data set.  This proves 
that there is a stronger testing reliability with isometric testing opposed to isokinetic. 
Figure 8: Isokinetic Strength Testing Reliability 
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Chapter V: 
Discussion 
 
Based on the results, we have discovered reliability in our methods for measuring volume 
and strength, but not in our stiffness methods.  Even though the results were fairly reliable, they 
could be improved in future studies.  When comparing the calculated muscle volume and 
strength values between day 1 and day 2, there are obvious discrepancies amongst the subjects.  
There is a strong trend for larger volume and strength measurements to be taken on testing day 2 
compared to day 1.  Although our data appears statistically reliable, it is important to analyze 
impending errors in order to further improve accuracy. 
 A potential source of error is in our measurement of muscle length between testing 
sessions.  Table 4 shows that the recorded muscle lengths varied between the two days in most 
subjects, showing up to a 4 cm difference.  The length values used to calculate the muscle 
volume were obtained manually through an external measurement across the calf.  This provided 
a curved surface opposed to the linear length measurement that would be more accurate.   
 
Table 4: Measured Muscle Length (in cm) 
Subject Medial Gastrocnemius Lateral Gastrocnemious 
 Day 1 Day 2 Day 1 Day 2 
1 20 24.5 19.5 21.5 
2 19.5 23.8 26.5 25 
3 18.3 19.5 20.5 20.5 
4 15 18.7 18.8 18.5 
5 19.2 19.3 21 23.6 
6 19.7 19.3 21.5 18.1 
 
The variation in length could potentially occur from slightly different tracking paths 
across the curved surface on day 1 compared to day 2.  During the testing session, the operator 
would angle the probe to capture the clearest ultrasound image.  Slight variations in probe angle 
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between sessions could influence the longitudinal tracking path and skew the length 
measurements for the 2 days. Initially, we predicted that any length variations would be 
compensated for in the calculations and would have little effect on the final volume values.  
However, the largest volume discrepancies between the two days were evident in subjects with 
more significant differences in length measurement.  
A second source of error could result from complications in scanning the cross-sectional 
slice images.  Our images were scanned continuously from the lateral to the medial muscle 
boundary.  When capturing the thickest slice of the muscle belly, the machine would 
occasionally distort the image due to the particular angle of the ultrasound probe.  The deformed 
muscle slice could have provided an altered cross-sectional area measurement, which ultimately 
would affect the calculated muscle volume.  
In a previous study, Infantolino et al proved the accuracy of the ultrasound method to 
determine muscle volume; however, his usage of the ultrasound differed slightly from the 
procedures we used in the current study.  Instead of capturing a single image of each muscle 
slice, Infantolino focused on piecing together a series of images taken across each muscle slice.  
This practice could remove the distortion error seen in the current study and provide a more 
accurate representation of the muscle.   
To improve precision, we can explore the use of ultrasound combined with motion 
capture to monitor the 3D location of the probe in space.  This method will potentially reduce 
errors by ensuring that the location and the angle of the probe is consistent from day 1 to day 2.  
Ultrasound cross-sectional area will be computed by piecing together a series of still images 
using Matlab software.  The motion capture equipment will process the location of the probe 
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during each image recording and the information will be integrated into the program to provide a 
more accurate volume calculation. 
In our stiffness reliability analysis we discovered a weak correlation between data values 
taken from the opposing test days, which provides evidence for faults in our methods.  Eby, et al. 
demonstrated the reliability of elastography in determining muscle stiffness.  This suggests that 
our inconsistent results between sessions are due to probable human error while testing.  In many 
subjects, there was evidence of significant variances in stiffness values recorded during the three 
10 second scans.  This could potentially result from changes in pressure applied by the tester 
while taking the elastography readings.  To achieve the greatest accuracy, the ultrasound probe 
should be placed lightly against the muscle belly without causing stress to the muscle.  Slight 
increases in applied pressure can alter stiffness readings and the muscle may appear stiffer.   
An additional source of error could be in the placement of the probe on the muscle belly.  
In the current study we did not monitor the exact location of the probe between testing days, 
which ultimately could alter the stiffness readings.  In future research, probe placement should be 
monitored and possibly oriented with nearby bony landmarks.  For our upcoming research, the 
probe location will be monitored by motion capture technology in order to improve consistency 
between testing sessions. 
 The discrepancies in our stiffness data reduce the validity of the muscle volume and 
stiffness regression analysis.  By improving our stiffness and volume methods in future research 
we will be able to approach a more accurate conclusion on the affect of muscle stiffness on 
muscle volume in a young population.  When comparing muscle volume to strength, we were 
also unable to establish a valid correlation.  Our plotted correlation showed a weak correlation 
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between muscle volume and strength, which contradicts past research showing a positive 
correlation. 
When evaluating the reliability of our methods of measuring strength, we discovered that 
they were inaccurate in determining the total strength of our subjects.  After analyzing the 
strength data from both the isometric and isokinetic strength tests it was obvious that some 
subjects did not provide consistent effort in force production.   This is evident when analyzing 
strength data from subject 1.  In this case, the subject’s isometric strength improved during the 
second testing session, while their isokinetic strength drastically declined.  The results prove that 
most subjects did perform higher on the second day opposed to the first.  We believe there may 
have been a learning effect in which the subjects’ strength improved after they became more 
comfortable with the testing equipment and the appropriate motions.  
 The correlation could potentially be swayed due to the exclusion of moment arm and 
soleus volume data as well.  Calf strength is determined by the combination of forces primarily 
by the MG, LG and soleus muscles.  Without calculating the volume of the soleus into the 
combined calf muscle volume, the correlation between the muscle volume and strength is 
inaccurate.  In addition, the moment arm data is necessary when calculating the total force 
exerted by each subject; without this information, our current strength data is not valid and 
cannot verify a correlation.    
Based on these results, we have concluded that strength testing is not a good 
determination of the effect of a training intervention due to the increased probability of error and 
miscalculation of an individual’s total strength.  Therefore, in future study we may analyze the 
effect of stiffness on muscle volume, while excluding strength testing.  If we do include strength 
training, we can apply electrical stimulation to the muscle to ensure that the participants are 
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exerting maximum force.   To compensate for the learning effect, researchers can allocate the 
first testing session for learning and collect the data on day 2. 
 Although we discovered potential errors in our testing methods, we found interesting 
results when plotting the correlation between muscle volume, stiffness and strength.  We have 
evidence that reduced muscle volume corresponds with increased muscle stiffness and attenuated 
muscular strength in the elderly population; however, we were looking for evidence in the 
younger subjects as well.  In our analysis of the relationship between muscle volume and 
stiffness, we discovered a slight negative correlation between the two factors in a young 
population, as demonstrated in Figures 9 and 10.  The correlation of determination of 0.10638 in 
the MG and 0.13322 in the LG demonstrates that the trend in not strong, however it does exist. 
 
. Figure 9: Muscle Volume vs. Muscle Stiffness of the Medial Gastrocnemius 
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Figure 10: Muscle Volume vs. Muscle Stiffness of the Lateral Gastrocnemius 
 
 Relationship of Muscular Strength on Stiffness.  A weak negative correlation was seen when 
comparing both isometric and isokinetic strength with stiffness as well, as shown in Figures 11 and 12.  
The stiffness values are an average of the values obtained from the LG and the MG.  This suggests that 
although the relationship is weak, after refining our methods we may be able to see a stronger 
correlation between the two factors in future research. 
 
Figure 11: Isometric Strength vs. Muscle Stiffness 
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Figure 12: Isokinetic Strength vs. Muscle Stiffness 
 
Relationship of Muscle Volume on Strength. In our analysis of muscle volume and 
strength, we were surprised to discover a very weak correlation between the two factors with the 
coefficients of determination ranging from .00027-.04929.  Figures 13 and 14 demonstrate the 
relationship between isometric and isokinetic strength with the LG, MG, and combined volume 
data.  The combined values represent the sum of the MG and LG volume data.  Past studies have 
proven a positive correlation between muscle volume and strength, therefore our 
misrepresentation of the relationship is likely due to errors in our methods.   
 
Figure 13: Isometric Strength vs. Muscle Volume 
 
  
MG 
y = -0.0408x + 180.66 
R2 = 0.00105 
LG 
y = 0.1668x + 93.76 
R2 = 0.04929 
Combined 
y = 0.126x + 274.42 
R2 = 0.00412 
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Figure 14: Isokinetic Strength vs. Muscle Volume 
 
We discovered potential errors in our methods of obtaining data, which influenced our 
regressions between volume, strength and stiffness.  By modifying our methods we can improve 
our approach and determine if there is a correlation between the factors in future research.  
Before taking the next step in this research project, our methods should be modified and retested 
for reliability.  The second reliability test should incorporate the use of motion capture with 
ultrasound and elastography technology.  Also, if we plan to test muscular strength, electrical 
stimulation should be applied to the muscle and additional data should be collected on the soleus 
and moment arms. 
The purpose of this study was to test the methods and provide the foundation for research 
that will analyze muscle stiffness as a potential cause of the reduced response to exercise.  We 
believe that age-related muscle stiffness interferes with mechanotransduction and ultimately 
limits muscle hypertrophy.  This could explain the reduced response to exercise seen in the 
elderly population and help to determine a potential cause of sarcopenia.  The next step would be 
to expand the research to an older population.  Future studies should include a larger sample size 
comparing data from both a younger and older population.  If there is in fact a correlation 
MG 
y = -0.3158x + 198.03 
R2 = 0.02202 
LG 
y = 0.2611x + 91.24 
R2 = 0.0422 
Combined 
y = -0.0548x + 289.27 
R2 = 0.00027 
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between muscle volume and stiffness, diagnosing a prospective cause of sarcopenia can allow 
researchers to move forward into discovering and implementing a treatment plan.      
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